RecruitingPhase 1

Study of XB010 in Subjects With Solid Tumors

NCT06545331

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

City of Hope Orange County Lennar Foundation Cancer Center

Irvine, California, United States

+19 additional locations

Contact

Exelixis Clinical Trials

Save this trial

City of Hope Orange County Lennar Foundation Cancer CenterIrvine, California, United States
UCLA Department of Medicine - Hematology/OncologyLos Angeles, California, United States
Georgetown University Medical CenterWashington D.C., District of Columbia, United States
Sarah Cannon Research Institute at Florida Cancer SpecialistsOrlando, Florida, United States
Winship Cancer InstituteAtlanta, Georgia, United States
University of Chicago Medical CenterChicago, Illinois, United States
Siteman Cancer CenterSt Louis, Missouri, United States
Montefiore Medical Center - Montefiore Medical ParkThe Bronx, New York, United States
Carolina BioOncology InstituteHuntersville, North Carolina, United States
Stephenson Cancer CenterOklahoma City, Oklahoma, United States
SCRI Oncology PartnersNashville, Tennessee, United States
NEXT AustinAustin, Texas, United States
Baylor University Medical CenterDallas, Texas, United States
University of Texas MD Anderson Cancer CenterHouston, Texas, United States
Inova Schar CancerFairfax, Virginia, United States
NEXT VirginiaFairfax, Virginia, United States
University Hospitals of Leicester NHS TrustLeicester, United Kingdom
Sarah Cannon Research Institute LondonLondon, United Kingdom
University College London Hospitals NHS Foundation TrustLondon, United Kingdom
The Christie NHS Foundation TrustManchester, United Kingdom